Author:
Jiao Boshen,Carlson Josh J.,Garrison Louis P.,Basu Anirban
Reference35 articles.
1. The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer;Garrison;Value Health,2009
2. The effect of formulary restrictions on patient and payer outcomes: a systematic literature review;Park;J Manag Care Spec Pharm,2017
3. Quantifying The Economic Burden of Drug Utilization Management on Payers, Manufacturers, Physicians, and Patients: study examines the economic burden of drug utilization management on payers, manufacturers, physicians, and patients;Howell;Health Aff,2021
4. The ethics of “fail first”: guidelines and practical scenarios for step therapy coverage policies;Nayak;Health Aff (Millwood),2014
5. American Society of Clinical Oncology statement on the impact of utilization management policies for cancer drug therapies;American Society of Clinical Oncology;J Oncol Pract,2017